Stay ahead in Biopharma
The Thermo Fisher Scientific™ global bio/pharma tour is an opportunity to collaborate and network directly with experts in technology innovation...
List view / Grid view
News
Lapatinib and trastuzumab shrinks HER2+ breast cancers within 11 days
11 March 2016 | By Victoria White
A trial has shown that lapatinib plus trastuzumab before surgery shrinks and may even destroy tumours in women with HER2+ breast cancer within 11 days. The EPHOS B trial studied 257 women with HER2 positive breast cancer in the short gap between initial diagnosis and surgery to remove their tumours.…
sarilumab demonstrates superiority to adalimumab in rheumatoid arthritis
11 March 2016 | By Victoria White
A Phase III study demonstrated that sarilumab was superior to adalimumab in improving signs and symptoms in patients with active RA...
Teva supports IVF Worldwide to improve knowledge of fertility preservation protocols
10 March 2016 | By Victoria White
Teva is to support IVF-Worldwide with a research grant to improve knowledge of fertility preservation protocols for women diagnosed with cancer...
Brussels Declaration on ADPKD one year on
10 March 2016 | By Victoria White
EAF experts have issued a collaborative letter to over 350 European decision makers celebrating the year one progress of the Brussels Declaration on ADPKD...
Positive results from Phase III study of RHB-105 for H. pylori infection
10 March 2016 | By Victoria White
The ERADICATE Hp Phase III study was intended to evaluate the safety and efficacy of RHB-105 as a first-line treatment for confirmed H. pylori bacterial infection...
GSK presents data on of Nucala in asthma patients stratified by eosinophil levels
The post-hoc analysis confirms the predictive nature of the relationship between baseline blood eosinophil counts and efficacy outcomes in patients treated with mepolizumab...
MenB vaccine Bexsero might see private uptake in the UK
9 March 2016 | By GlobalData
The UK Department of Health’s rejection of a petition to expand the routine administration of MenB vaccine Bexsero may lead to parents and physicians to consider purchasing the vaccine themselves...
Lenvatinib approved in Israel for patients with advanced thyroid cancer
9 March 2016 | By Victoria White
From today, people in Israel with radioactive iodine refractory differentiated thyroid cancer will have access to Eisai’s Lenvima (lenvatinib)...
Aprea closes EUR 46 million Series B financing round
9 March 2016 | By Victoria White
Aprea says the funds will be used to advance the clinical development of its lead programme APR-246, a first-in-class anticancer compound reactivating the tumour suppressor protein p53...
Study data published for Cresemba in patients with mucormycosis
9 March 2016 | By Victoria White
Cresemba (isavuconazonium sulfate) is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive aspergillosis and invasive mucormycosis...
Sanat Chattopadhyay named as president of Merck Manufacturing Division
8 March 2016 | By Victoria White
Sanat Chattopadhyay, who's appointment will be made effective on 1 April 2016, will succeed Willie A. Deese...
Spiriva Respimat effective regardless of allergy subtype, study finds
8 March 2016 | By Victoria White
The addition of Spiriva Respimat to other asthma maintenance therapies helps improve asthma symptom control regardless of allergy subtype...
Sanofi Pasteur and MSD to end joint vaccines operations in Europe
8 March 2016 | By Victoria White
Upon concluding their joint venture, Sanofi Pasteur and MSD plan to integrate their respective European vaccine businesses into their operations...
Systech to host Uniquity Europe global brand protection conference
8 March 2016 | By Systech International
Global brands focus on consumer safety at Amsterdam conference...
